- Home
- Applications
- north america
- disease target
Show results for
Refine by
Disease Target Product Applications In North America
3 applications found
Fractyl Health was founded in 2011 with a dedication to developing novel therapeutic interventions that have the potential to help reverse the metabolic disease epidemic. Despite advances in treatment over the past 50 years, metabolic diseases in general, and type 2 diabetes (T2D) in particular, continue to be a principal and rapidly growing driver of morbidity and mortality in the 21st century. Our goal is to transform T2D treatment from chronic blood glucose management to ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)
Using our platform, we are developing mRNA medicines for diverse uses and delivering them to patients across the globe. We are currently focusing on 4 medical areas - infectious diseases, immuno-oncology, rare diseases and autoimmune ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
Secondly, we can realize the mass production of protein drugs, antibiotic drugs and recombinant antibodies by developing genetic recombination drugs. Thirdly, to achieve targeted treatment of rare diseases and tumors through research on small nucleic acid drugs. In addition, we can repair abnormal genes by performing gene editing at the DNA level to achieve targeted mutations of genes. The treatment of diseases by genetic methods are more ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)